With Type 1 Diabetes Delay Possible, Focus Now on Screening With Type 1 Diabetes Delay Possible, Focus Now on Screening

The FDA approval of teplizumab for the delay of type 1 diabetes highlights the need to cost-effectively identify those at risk who could potentially receive it.Medscape Medical News
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Diabetes & Endocrinology News Source Type: news